Literature DB >> 34080913

Squamous Metaplasia in a Borderline Phyllodes Tumor-an Undocumented Histological Finding in Male Breast: Report of a Case and Review of Literature.

Chinmayee Panigrahi1, Shilpy Jha1, Pankaj Kumar1, Tushar S Mishra1, Prakash K Sasmal1, Amit K Adhya1.   

Abstract

Phyllodes tumor is a paradigm of fibroepithelial neoplasm that accounts for <1% of the breast neoplastic lesions usually detected in females and uncommonly in the male breast. The World Health Organization classifies the tumor into benign, borderline, and malignant based on the predefined morphological criteria. Squamous differentiation in phyllodes tumor is epithelial metaplasia, which has been occasionally documented in English literature. We report the first undocumented case of a recurrent borderline phyllodes tumor with cystic squamous metaplastic change in a 32-year-old male patient. The histology was that of a fibroepithelial neoplasm with the typical leaf-like projections and cystic spaces lined by squamous epithelium containing keratin debris. The purpose of presenting this case is to elucidate the pathogenesis and discuss other malignant and benign breast lesions that may be included in the differential diagnosis when evaluating a breast lesion with squamous metaplasia, particularly in the context of fine-needle aspirates.

Entities:  

Keywords:  borderline; cyst; male breast; phyllodes tumor; squamous metaplasia

Mesh:

Year:  2021        PMID: 34080913     DOI: 10.1177/10668969211022017

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

Review 1.  An Update on the General Features of Breast Cancer in Male Patients-A Literature Review.

Authors:  Sinziana Ionescu; Alin Codrut Nicolescu; Marian Marincas; Octavia-Luciana Madge; Laurentiu Simion
Journal:  Diagnostics (Basel)       Date:  2022-06-26

2.  Application of CT Imaging in Differential Diagnosis and Nursing of Endocrine Tumors.

Authors:  Xue Jiang; Weiwei Xu; Ying Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-08-08       Impact factor: 3.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.